Type 2 diabetes mellitus: time to change the concept

Código QR

Type 2 diabetes mellitus: time to change the concept

Diabetes mellitus is a heterogeneous group of diseases that, although unified by a number of characteristics, require a differential thera- peutic approach. Current review discusses key pathogenic features of type 2 diabetes mellitus that determine therapy goals and options in management. We further...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shmuel Levit, Yury Ivanovich Filippov, A S Gorelyshev
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2013
Materias:	type 2 diabetes mellitus body mass obesity insulin incretins bariatric surgery cardiovascular mortality remission Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/99cd488a53e542c89411f237c5db27c8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Response to Comment on ?Type 2 diabetes mellitus ? time to change the concept?
por: Shmuel Levit, et al.
Publicado: (2014)

Insulin/weight ratio may serve as a predictor of success during insulin pump therapy in type 2 diabetes patients: a proof-of-concept study
por: Shmuel Levit, et al.
Publicado: (2015)

Comments to: ?Type 2 diabetes mellitus ? time to change the concept?
por: Oleg Viktorovich Udovichenko
Publicado: (2014)

Ileal transposition in surgical treatment for type 2 diabetes mellitus
por: Oleg Viktorovich Kornyushin, et al.
Publicado: (2015)

New indications for exenatide therapy of type 2 diabetes mellitus
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2010)

Possibilities of metabolic surgery for the treatment of type 2 diabetes mellitus in patients with grade 1 alimentary obesity
por: Vladimir V. Salukhov, et al.
Publicado: (2018)

Pathogenetic significance of single nucleotide polymorphisms in the gastric inhibitory polypeptide receptor gene for the development of carbohydrate metabolism disorders in obesity
por: Daria S. Skuratovskaia, et al.
Publicado: (2016)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
por: Ekaterina Alekseevna Shestakova
Publicado: (2011)

Evolution of biliopancreatic diversion in the treatment of morbid obesity and type 2 diabetes mellitus
por: Natalya S. Bordan, et al.
Publicado: (2017)

Vildagliptin and its role in the treatment of diabetes mellitus
por: Yury Shavkatovich Khalimov
Publicado: (2010)

Selected aspects of insulin pump therapy and continuous glucose monitoring in real time (in relation to the letter of E.D.Gorbachev)
por: Yury Ivanovich Filippov, et al.
Publicado: (2010)

New prospects in the treatment of diabetes mellitus
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2012)

Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
por: Yury Ivanovich Filippov, et al.
Publicado: (2012)

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
por: Yury Ivanovich Suntsov
Publicado: (2012)

Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
por: Shmuel Levit, et al.
Publicado: (2016)

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
por: Nina A. Petunina, et al.
Publicado: (2018)

Dynamics of main epidemiological characteristics of type 1 diabetes mellitus in children of the Russian Federation
por: Tatiana Yur'evna Shiryaeva, et al.
Publicado: (2010)

Adipokines in metabolic processes regulating during obesity treatment
por: Larisa Sergeevna Litvinova, et al.
Publicado: (2014)

Insulin pump therapy in type 1 diabetes mellitus: education effectiveness and quality of life
por: Lyudmila Ibragimovna Ibragimova, et al.
Publicado: (2012)

Corrigendum: The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 (Diabetes mellitus. 2019;22(3). doi: 10.14341/DM10194)
por: Elena V. Pokrovskaya, et al.
Publicado: (2019)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2
por: Elena V. Pokrovskaya, et al.
Publicado: (2019)

Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
por: Vladimir V. Salukhov, et al.
Publicado: (2016)

Type 1 diabetes mellitus in children and adolescents of Russian Federation: key epidemiology trends
por: Tatiana Yur'evna Shiryaeva, et al.
Publicado: (2013)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011)

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
por: Vladimir Ivanovich Kudinov, et al.
Publicado: (2012)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
por: Vladimir Ivanovich Zoloedov, et al.
Publicado: (2012)

Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2013)

Epidemiological characteristics of diabetes mellitus and its complications in the Omsk region
por: Marina Lukmanovna Sayfullina, et al.
Publicado: (2010)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
por: Nina Viktorovna Bolotova, et al.
Publicado: (2010)

Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
por: Sergey V. Kakorin, et al.
Publicado: (2016)

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011)

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
por: Elena Valer'evna Biryukova
Publicado: (2014)

The 3rd International Conference on Advanced Technologies - Treatments for Diabetes (ATTD), Basel, 10 - 13 February 201
por: Yury Ivanovich Filippov
Publicado: (2010)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
por: Tatiana Evgen'evna Taranushenko, et al.
Publicado: (2012)

Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs
por: Olga D. Ostroumova, et al.
Publicado: (2018)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
por: Elena Alexandrovna Kharlashina, et al.
Publicado: (2011)

Genetic framework of type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

A review of mortality in type 2 diabetes mellitus
por: Nailya Sayfullaevna Asfandiyarova
Publicado: (2015)